The Index

Companies

400 dossiers · 1 need attention

A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.

Table Cards

Filters2

IndustryAll Agtech15 AI-Bio22 AI & Machine Learning26 Beauty Personal Care1 Biopharma21 Cloud Computing

1 of 400 company· AI-Bio

FreshWebTR 8

AI-Bio

Amyris

A 20-year, ~$1.7B-deficit cautionary tale of synbio that hit the same wall every fermentation pure-play hits (scale-up economics never closed the gap to chemistry), capped by an SEC revenue-recognition charge and a Chapter 11 that wiped equity to zero — the emerged "Amyris 2.0" is a smaller, Doerr-controlled private with no public equity to buy and no edge proven; AVOID / un-investable, watch only as the canonical synbio-failure comp.

View profile